Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

The Lancet Oncology
Ian E KropHans Wildiers

Abstract

In the randomised, parallel assignment, open-label, phase 3 TH3RESA study, progression-free survival was significantly longer with trastuzumab emtansine versus treatment of physician's choice in previously treated patients with HER2-positive advanced breast cancer. We report results from the final overall survival analysis of the TH3RESA trial. Eligible patients for the TH3RESA trial were men and women (aged ≥18 years) with centrally confirmed HER2-positive advanced breast cancer previously treated with both trastuzumab and lapatinib (advanced setting) and a taxane (any setting) and with progression on two or more HER2-directed regimens in the advanced setting. Patients had to have an Eastern Cooperative Oncology Group performance status of 0-2, left ventricular ejection fraction of at least 50%, and adequate organ function. Patients were randomly assigned (2:1) by an interactive voice and web response system with permuted block randomisation in blocks of six to receive trastuzumab emtansine (3·6 mg/kg intravenously every 21 days) or treatment of physician's choice administered per local practice. Randomisation was stratified by world region, number of previous regimens for advanced breast cancer, and presence of visceral disea...Continue Reading

Citations

Dec 8, 2017·Future Oncology·Deborah B Doroshow, Patricia M LoRusso
Aug 9, 2017·Nature Reviews. Clinical Oncology·Otto Metzger-Filho, Eric P Winer
Nov 25, 2017·Expert Opinion on Pharmacotherapy·Jesus Anampa, Joseph A Sparano
Jan 10, 2018·Frontiers in Immunology·Isabel Corraliza-GorjónLeonor Kremer
Jun 14, 2018·The New England Journal of Medicine·Sharon H Giordano
Jan 18, 2018·European Journal of Endocrinology·Leandro KasukiMônica R Gadelha
Sep 11, 2018·Expert Opinion on Investigational Drugs·Enrique Soto-Perez-De-CelisArti Hurria
Oct 7, 2018·Cancer·Sonia PernasSara M Tolaney
Nov 7, 2018·Expert Opinion on Pharmacotherapy·Gaia GiannoneFilippo Montemurro
Nov 15, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Ali Alkan
Nov 21, 2018·Expert Opinion on Drug Safety·Lidia Rita CorsiniAntonio Russo
Dec 6, 2018·The New England Journal of Medicine·Gunter von MinckwitzUNKNOWN KATHERINE Investigators
Jan 9, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J I Chacón López-MuñizS López-Tarruella Cobo
Apr 2, 2019·Current Treatment Options in Oncology·Noam PondéMartine Piccart
Jun 6, 2019·Breast Cancer Research and Treatment·Guy JerusalemSung-Bae Kim
Mar 13, 2019·Journal of the National Cancer Institute·Michael J BirrerRichard C Bates
Dec 2, 2017·Current Opinion in Obstetrics & Gynecology·Nadia Harbeck
Oct 30, 2019·The Journal of Clinical Investigation·Koji HarataniKazuhiko Nakagawa
Apr 3, 2020·American Society of Clinical Oncology Educational Book·Danielle FileLisa A Carey
Jul 18, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cristina SauraUNKNOWN NALA Investigators
Jul 24, 2020·Expert Opinion on Investigational Drugs·Rupert Bartsch
Aug 20, 2020·CA: a Cancer Journal for Clinicians·Grace M ChoongCiara C O'Sullivan
Mar 23, 2019·Cancers·Denis M CollinsGerhard Niederfellner
May 19, 2019·Journal of Hematology & Oncology·Dan ZhaoJoseph Chao
Aug 27, 2019·Expert Review of Anticancer Therapy·Giulia VialeGiuseppe Curigliano
Jun 13, 2020·Nature Reviews. Clinical Oncology·Roberto Carmagnani PestanaDavid S Hong
Jul 25, 2018·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Emi NoguchiYasuhiro Fujiwara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.